Joaquin Duato

Executive Vice President,
Worldwide Chairman,
Pharmaceuticals

Joaquin Duato is a globally experienced, values-driven pharmaceutical leader and currently the Executive Vice President and Worldwide Chairman, Pharmaceuticals, at Johnson & Johnson, the world’s premiere healthcare company and 5th largest pharmaceutical business.  He is a respected industry leader and is the Chairman-Elect of the Pharmaceutical Research and Manufacturers of America (PhRMA).

Joaquin played an instrumental role in leading the dramatic turnaround of the Johnson & Johnson pharmaceuticals business.  A 27-year veteran of the Company, Joaquin was named Company Group Chairman of the Americas in 2009.  He then continued leading the global transformation upon his appointment as Worldwide Chairman in 2011.  With a focus on creating innovative commercial solutions and processes to support the Company’s innovative medicines, he inspires employees to focus on transforming the lives of patients.  The results are clear: with 16 new products launched since 2009 and 10 potential billion dollar medicines expected to be filed before 2019, the Johnson & Johnson pharmaceuticals sector is poised to remain one of the fastest growing top 10 pharmaceutical companies globally.

As a dual citizen of Spain and the US, Joaquin brings a unique international perspective to his work.  With a career spanning three countries and two regions, he appreciates the value of diversity of experiences and opinions.  He brings this to bear externally as an active Board member of the US Spain Council and internally as the Executive Sponsor of the African American Leadership Council.  His passion for nurturing a culture of diversity was recognized in 2015 when he was named one of America’s Top 10 Hispanic Business Leaders by Hispanic Career World

Joaquin also has a passion for learning, with an undergraduate degree in economics and business, an MBA from ESADE, Barcelona and a Masters of International Management from Thunderbird, Phoenix.  He is a champion of improving access to both health literacy and education more broadly through his role as Board Member of the international charity Save the Children.  He also mentors MBA graduates at universities around the world and through his role on the International Advisory Board of the ESADE Business School. 

Ultimately, he approaches every day with a clear sense of purpose and urgency, inspired by the words of Dr. Paul Janssen, “the patients are waiting.”

 

Joaquin News & Multimedia

J&J Visit to Puerto Rico

J&J Puerto Rico

Chairman and CEO Alex Gorsky and senior leaders Kathy Wengel and Joaquin Duato visited our manufacturing facilities in Puerto Rico. They also met with employees. View a photo gallery of visit highlights.

Helping Syrian Refugees

Helping Syrian Refugees

Joaquin Duato, Worldwide Chairman of Pharmaceuticals, announced at the November 2015 Save the Children gala that Johnson & Johnson would donate $1.75 million dollars to help families and children affected by the Syrian Refugee Crisis.

Leadership Honor

Leadership Honor

Joaquin Duato, Worldwide Chairman, Pharmaceuticals, is named as one of the top U.S business leaders by Hispanic Career World.

Cultivating Talent Diversity

Cultivating Talent Diversity

Johnson & Johnson understands the business value gained by employing an international workforce with  diverse backgrounds and cultural experiences. Joaquin Duato, Worldwide Chairman for Pharmaceuticals and dual U.S. & Spain citizen, writes on our corporate blog about cultivating that talent.

Joaquin Duato, Gulf Business Magazine

Johnson & Johnson's Pharma Ambitions

Joaquin Duato, Worldwide Chairman, Pharmaceuticals, writes about the start of the Global Moms Relay that Johnson & Johnson is launching in partnership with the United Nations Foundation. Every day until Father’s Day, a celebrity, community leader or everyday mom and dad will share a personal story about what kind of future they envision for their family and the world in 2030.

Joaquin Duato Jennifer Garner Moms Social Good

2030 and Beyond

Joaquin Duato, Worldwide Chairman, Pharmaceuticals, writes about the start of the Global Moms Relay that Johnson & Johnson is launching in partnership with the United Nations Foundation. Every day until Father’s Day, a celebrity, community leader or everyday mom and dad will share a personal story about what kind of future they envision for their family and the world in 2030.

Helping Others

Helping Others

Joaquin Duato, Worldwide Chairman, Pharmaceuticals at Johnson & Johnson, recently spoke about his passion and commitment to diversity and inclusion. Read his remarks in our corporate blog.

Fortune's Most Admired

Fortune ranks J&J as top pharmaceutical company on its Most Admired List

For the second consecutive year FORTUNE Magazine ranked Johnson & Johnson and its Janssen Pharmaceutical Companies #1 in the Pharmaceuticals category on its annual World’s Most Admired Companies list. J&J senior leaders Paul Stoffels, M.D., Chief Scientific Officer and Worldwide Chairman, Pharmaceuticals, and Joaquin Duato, Worldwide Chairman, Janssen Pharmaceutical Companies, co-authored a blog about this honor and our commitment to healthcare innovation.

PwC’s 18th Annual Global CEO Survey

PwC's 18th Annual Global CEO Survey

Joaquin Duato, Worldwide Chairman of our Janssen Pharmaceutical Companies, was asked to participate in the 18th Annual PricewaterhouseCoopers (PwC) LLC Global CEO Survey on behalf of Johnson & Johnson and our senior leadership team. Joaquin shares some of his business perspectives in this interview.

Joaquin Duato talks to CNBC about fast-tracking an Ebola vaccine

CNBC's Meg Tirrell speaks to Joaquin Duato, Worldwide Chairman, Pharmaceuticals at Johnson & Johnson about the Company's partnership with the National Institutes of Health to fast track its Ebola vaccine program to begin human testing by early 2015.

Joaquin Duato Interview with Bloomberg

Joaquin Duato Interview with Bloomberg

In an interview on Bloomberg TV, Joaquin Duato, Worldwide Chairman, Pharmaceuticals at Johnson & Johnson, discussed our pharmaceutical products launched since 2009, coupled with the new products expected to emerge from our pipeline, are planned to account for nearly half of the total sales in the segment by 2017.

Acting on Behalf of the Children

Acting on Behalf of the Children

Joaquin Duato, Worldwide Chairman, Pharmaceuticals at Johnson & Johnson guest authored a blog on Huffington Post’s Global Motherhood blog about his September 2014 trip to Texas to learn about the Save the Children humanitarian work being done to help children.

For the Children's Future

For the Children's Future

Johnson & Johnson’s Joaquin Duato and Sarah Colamarino write about the importance of investing in a child’s future from birth through the important developmental years and beyond. Learn how the long-standing partnership between Save the Children and J&J continues to help support children around the globe.